Endogastric Solutions Logo
  • Home
  • Patients
    • Take me to Gerdhelp.com
  • Providers
    • TIF 2.0®
      • EsophyX® Device
    • cTIF™
    • Support
      • Training and Education
      • Reimbursement
      • Community Outreach
      • Regulatory Labeling
      • Data & Bibliography
    • Referring Physicians
    • Events
  • About Us
    • Leadership
      • Executive Team
      • Medical Advisory Board
      • Board of Directors
    • Careers
    • Investors
    • News
      • Press Releases
      • Videos
  • Contact
Endogastric Solutions Logo
  • Patients
  • Providers
  • About Us
  • Contact
EndoGastric Solutions Announces Data Presented at ACG 2018 Provide Additional Validation of the Safety and Clinical Efficacy of TIF 2.0 Procedure for the Treatment of GERD

EndoGastric Solutions Announces Data Presented at ACG 2018 Provide Additional Validation of the Safety and Clinical Efficacy of TIF 2.0 Procedure for the Treatment of GERD

Oct 29, 2018

Amit Sohagia, MD received ACG’s Outstanding Poster Presenter Award for TIF 2.0 procedure poster REDMOND, Wash. – EndoGastric®Solutions today announced the presentation of three posters at the American College of Gastroenterology (ACG) 2018 Annual Scientific Meeting...
EndoGastric Solutions Announces New Data at Digestive Disease Week 2018 Supporting the Durability and Efficacy of TIF 2.0 Procedure for GERD Patients

EndoGastric Solutions Announces New Data at Digestive Disease Week 2018 Supporting the Durability and Efficacy of TIF 2.0 Procedure for GERD Patients

Jun 2, 2018

TIF 2.0 procedure provides improved quality of life and elimination of daily PPI use for up to 10 years in patients with symptomatic GERD; TIF 2.0 procedure combined with laparoscopic hiatal hernia repair is a safe and effective option for patients with severe GERD...
EndoGastric Solutions Announces Publication of Meta-Analysis Further Validating TIF 2.0 procedure as an Appropriate Treatment Option for Refractory GERD Patients

EndoGastric Solutions Announces Publication of Meta-Analysis Further Validating TIF 2.0 procedure as an Appropriate Treatment Option for Refractory GERD Patients

May 31, 2018

TIF Procedure offers excellent short and long-term relief for the majority of chronic GERD patients. REDMOND, Wash – EndoGastric® Solutions today announced the publication of a meta-analysis supporting the clinical utility of Transoral Incisionless Fundoplication...
EndoGastric Solutions Announces Publication of 5 Year TEMPO Data Confirming Lasting Improvement of GERD Symptoms with TIF 2.0 Procedure

EndoGastric Solutions Announces Publication of 5 Year TEMPO Data Confirming Lasting Improvement of GERD Symptoms with TIF 2.0 Procedure

Feb 7, 2018

Cost comparison analysis indicates significantly lower healthcare utilization by TIF procedure patients REMOND, Wash. – EndoGastric® Solutions today announced that Surgical Innovation: Advances in Minimally Invasive Surgical Science, Technology, and Training has...
« Older Entries
Next Entries »
EndoGastric Solutions logo
  • Patients
  • Providers
  • About Us
  • Contact Us
  • GERDHelp for Patients
  • References
  • Privacy
  • Terms of Use
  • Social Media Policy
  • Corporate Compliance
  • Facebook
  • X
  • Instagram
  • RSS
© 2023 EndoGastric Solutions, Inc. All rights reserved.
EndoGastric, EsophyX, SerosaFuse, TIF, TIF 2.0 and cTIF names and logos, are registered trademarks of EndoGastric Solutions. All other product names and logos are trademarks or registered trademarks of their respective holders.